Register
Login:
Share:
Email Facebook Twitter

Be a contrarian investor says Ranjeet Singh Watch here

Be a contrarian investor says Ranjeet Singh


Sareum Share Chat (SAR)



Share Price: 0.90Bid: 0.85Ask: 0.95Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.10Spread as %: 11.76%Open: 0.875High: 0.90Low: 0.875Yesterday’s Close: 0.90


Share Discussion for Sareum


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


Hondadave
Posts: 3,771
Off Topic
Opinion:No Opinion
Price:0.90
RE: Hondadave ?
Today 11:11
Hi thoth2
Not at all I want this to do well believe me. Just been stung by another share that has a few similarities to sar and am getting twitchy.
We've had so much good news recently I figured the sp would be in the 2's by now at least?
I really appreciate your posts so thanks for that. I will keep the negative posts to myself from now on.
Gl
 
Thoth2
Posts: 1,407
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.90
Hondadave ?
Today 01:01
Glass half emty or full? Only post on a down wiggle ? Not in an up ?
Lottohopes
Posts: 1,618
Off Topic
Opinion:No Opinion
Price:0.90
RE: a lot of interest
Sat 23:37
Caffeine also reduces probability of getting PD.
Thoth2
Posts: 1,407
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.90
RE: a lot of interest
Sat 19:37
Technically he had ALS. 45% lower risk of developing PD if a smoker. Not publicised much but the evidence is there.
JonTangle
Posts: 371
Off Topic
Opinion:No Opinion
Price:0.90
RE: a lot of interest
Sat 19:26
Michael J Fox was a heavy smoker and he ended up with Parkinson's.
Thoth2
Posts: 1,407
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.90
elcap
Fri 17:05
some alzheimers stuff may be of interest. it may be an overreaction of the immune system and TYK2 implicated
https://www.ncbi.nlm.nih.gov/pubmed/20484629
https://www.statnews.com/2016/03/31/alzheimers-immune-synapses/
elcap
Posts: 186
Off Topic
Opinion:No Opinion
Price:0.90
RE: a lot of interest
Fri 12:41
Thanks thoth
Thoth2
Posts: 1,407
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.90
View Thread (2)
RE: a lot of interest
Fri 11:56
personally. a lot of it is still early science. CAR-T and immunotherapy getting lots of trial flops. but early research interesting. Tyk2 inhibition look sto have a role in preventing alzheimers. (but early research stage still). Little known fact. no one who smokes gets parkinsons (very cheap preventative measure is 20 bensons a day).
Combo therapies are great. segements the market into effective niches (Sierra is doing that with Chk1, awaiting announcement imminently on which combos, and John currentlt doing combo assessment on Tyk2 (afgaian awaiting announcement on pre clinical results). its the way to go..
elcap
Posts: 186
Off Topic
Opinion:No Opinion
Price:0.90
a lot of interest
Fri 11:30
Hi all, there seems to be a lot of news around at the moment (on the tv) around advances in treatment of cancer (t_cells) and news again yesterday about huge advances in treatments (combo of 2 existing drugs) in curing alzheimers and parkinsons.

I just wondered if a) SAR can take advantage of current interest. B) do the advances in treatment help / hinder the work SAR are doing. Clearly if cures are established before SAR get product to market our product becomes less valued.

Obviously all advance on these terrible illnesses is fantastic, but I am just interested to hear views of you guys, as I am not an expert.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.